These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3486412

  • 21. [Changes in the functional activity of blood lymphocytes in patients with destructive pulmonary tuberculosis during the treatment].
    Kibrik BS, Krylova GO, Kolesnikov VA.
    Probl Tuberk; 1991; (10):63-6. PubMed ID: 1788236
    [Abstract] [Full Text] [Related]

  • 22. Thymosin restores T cell function and reduces the incidence of amyloid disease in casein-treated mice.
    Scheinberg MA, Goldstein AL, Cathcart ES.
    J Immunol; 1976 Jan; 116(1):156-8. PubMed ID: 1081998
    [Abstract] [Full Text] [Related]

  • 23. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis].
    Stasiak A, Dudkiéwicz H, Dabrowski M, Dabrowska B, Wasowska B, Brzosko W.
    Pol Tyg Lek; 1983 Mar 28; 38(13):389-92. PubMed ID: 6605525
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical trial of treatment with the preparation TFX "Polfa" of 4 patients with acquired immunologic deficiency syndromes].
    Romański B, Montowska L, Zbikowska-Götz M, Staszyńska M.
    Pol Tyg Lek; 1983 Mar 28; 40(40-41):1139-42. PubMed ID: 3911181
    [No Abstract] [Full Text] [Related]

  • 25. [Experimental study of the effect of rifampicin on antituberculosis immunity].
    Chernushenko EF, Shiniberov VA.
    Probl Tuberk; 1983 Feb 28; (2):47-51. PubMed ID: 6601802
    [No Abstract] [Full Text] [Related]

  • 26. [Efficacy of treating patients with disseminated forms of destructive pulmonary tuberculosis using chemical preparations and T-activin].
    Chukanov VI, Gergert VIa, Khomenko IS.
    Probl Tuberk; 1989 Feb 28; (6):30-3. PubMed ID: 2771908
    [Abstract] [Full Text] [Related]

  • 27. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG, Nikitina OI.
    Probl Tuberk; 1990 Feb 28; (5):11-4. PubMed ID: 2388887
    [Abstract] [Full Text] [Related]

  • 28. [Immunocorrective therapy of autoimmune and subacute thyroiditis].
    Balabolkin MI, Arion VIa, Sakaeva NA.
    Sov Med; 1989 Feb 28; (6):106-8. PubMed ID: 2799479
    [No Abstract] [Full Text] [Related]

  • 29. [Immunologic correction using thymus gland preparation (T-activin) in the programmed treatment of patients with non-lymphoid leukemia].
    Drozdova TS, Makhonova LA, Maiakova SA, Tabagari DZ.
    Gematol Transfuziol; 1990 Jan 28; 35(1):14-6. PubMed ID: 2328895
    [Abstract] [Full Text] [Related]

  • 30. Editorial: Thymosin therapy creates a "Hassall"(?).
    Hong R, Horowitz S.
    N Engl J Med; 1975 Jan 09; 292(2):104-5. PubMed ID: 1078550
    [No Abstract] [Full Text] [Related]

  • 31. Letter: Effect of thymosin on B-lymphocyte function.
    Wara DW, Ammann AJ.
    N Engl J Med; 1975 Sep 04; 293(10):507. PubMed ID: 1080248
    [No Abstract] [Full Text] [Related]

  • 32. [Levamisole correction of immunologic disorders in patients with lymphocytic leukemia].
    Kozak VP.
    Vrach Delo; 1985 May 04; (5):74-7. PubMed ID: 3874479
    [No Abstract] [Full Text] [Related]

  • 33. [Correction with T-activin of secondary immunodeficiency in inflammatory diseases of female internal genital organs].
    Pogodin OK, Samorodinova LA, Matveeva NK, Sukhikh GT.
    Akush Ginekol (Mosk); 1991 Apr 04; (4):40-4. PubMed ID: 1862873
    [Abstract] [Full Text] [Related]

  • 34. Influenza: response of T-cell lymphopenia to thymosin.
    Scheinberg M, Blacklow NR, Goldstein AL, Parrino TA, Rose FB, Cathcart ES.
    N Engl J Med; 1976 May 27; 294(22):1208-11. PubMed ID: 1083484
    [Abstract] [Full Text] [Related]

  • 35. [The effect of thymoptin in the specific immunotherapy of experimental microbial allergy].
    Sukhodoeva GS, Shamsutdinova GS, Andreeva NA.
    Zh Mikrobiol Epidemiol Immunobiol; 1995 May 27; (6):58-9. PubMed ID: 8553760
    [No Abstract] [Full Text] [Related]

  • 36. Editorial: Thymic cells and humoral factors as therapeutic agents.
    Wara DW, Ammann AJ.
    Pediatrics; 1976 May 27; 57(5):643-6. PubMed ID: 1084986
    [No Abstract] [Full Text] [Related]

  • 37. [Correction of immunologic reactivity in elderly patients with diffuse toxic goiter].
    Epishin AV, Epishina NA.
    Sov Med; 1990 May 27; (2):68-70. PubMed ID: 2356533
    [No Abstract] [Full Text] [Related]

  • 38. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa, Ivanushkin EF.
    Khirurgiia (Mosk); 1984 Nov 27; (11):44-8. PubMed ID: 6335205
    [No Abstract] [Full Text] [Related]

  • 39. [Use of chlotazol as an immunomodulating agent in chronic bronchitis].
    Kleĭner AI, Shmuter LM, Makotchenko VM, Efremova VA, Khodzhaĭ IaI, Trukh VS.
    Klin Med (Mosk); 1991 Apr 27; 69(4):58-60. PubMed ID: 1865653
    [Abstract] [Full Text] [Related]

  • 40. [Effect of thymalin on the immunological indices and morphofunctional structure of the uterus in guinea pigs with endometrial hyperplasia].
    Zaporozhan VN, Khait OV, Li LN.
    Biull Eksp Biol Med; 1989 Feb 27; 107(2):251-3. PubMed ID: 2784333
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.